Jane E. Kiernan

Board Member

Jane E. Kiernan has served as a member of our board of directors since October 2022. Ms. Kiernan has over 30 years of executive and management leadership in healthcare with both public and private companies. She joined Surgimatix, Inc., a privately held medical device company pioneering a novel suture-based soft tissue fixation technology for minimally invasive surgical procedures, as Chief Business Officer in May 2020 and became its Chief Executive Officer and a board member in February 2022. In January 2018, Ms. Kiernan cofounded K2 Biotechnology Ventures, an organization engaged in developing and commercializing university and medical center innovations in partnership with venture capital, healthcare corporations and philanthropic healthcare foundation partners. From October 2010 to May 2017, Kiernan served as the CEO of Salter Labs, a manufacturer of specialty respiratory and airway management medical devices. From 2000 to September 2010, Kiernan held executive and general management positions with Baxter Healthcare Corporation. Ms. Kiernan serves on the board of Pharmazz, a private biopharmaceutical company, and AVeta Medical, a private medical device company. She previously served on the board of directors of Axonics, Inc. (NASDAQ: AXNX), a publicly traded global leader in incontinence therapies acquired by Boston Scientific in 2024; Endologix, Inc. (OTC: ELGXQ), a publicly traded provider of minimally invasive treatments of aortic disorders; and American Medical Systems (NASDAQ: AMMD), a publicly traded life sciences company acquired by Endo Pharmaceuticals. Kiernan holds a B.S. degree in business from Southern Methodist University.